# QuidelOrtho Corp: Form 10-K/A for the period ended Dec 31, 2023

- Company: [QuidelOrtho Corp](/companies/qdel.md) (CIK 1906324)
- Form: 10-K/A
- Filed: 2024-08-01
- Accepted by EDGAR: Jul 31, 2024, 18:33 ET
- Period: 2023-12-31
- Accession: 0001906324-24-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000043/qdel-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000043/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-02 to 2023-12-31 | $3.00bn | us-gaap:Revenues |
| Research and development | 12 months, 2023-01-02 to 2023-12-31 | $246.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2023-01-02 to 2023-12-31 | $763.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2023-01-02 to 2023-12-31 | $139.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2023-01-02 to 2023-12-31 | −$19.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-02 to 2023-12-31 | −$10.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-01-02 to 2023-12-31 | −$0.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-01-02 to 2023-12-31 | −$0.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-01-02 to 2023-12-31 | 66,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-01-02 to 2023-12-31 | $280.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-02 to 2023-12-31 | $209.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2023-01-02 to 2023-12-31 | $7.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2023-12-31 | $118.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | $1.31bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $8.56bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $833.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-12-31 | $3.56bn | us-gaap:Liabilities |
| Long-term debt | at 2023-12-31 | $2.42bn | us-gaap:LongTermDebt |
| Current portion of debt | at 2023-12-31 | $139.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-12-31 | $5.01bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1906324/000190632424000043/qdel-20231231.htm

Filed Aug 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001906324-24-000043. Last ingested by Listed: Nov 3, 2026, 19:03 ET. No prices; not investment advice.
